Search Results 551-560 of 109021 for b-

  1. News - Timothy B. Curry, M.D., Ph.D. - Mayo Clinic

    Timothy B. Curry, M.D., Ph.D. Anesthesiologist. Request an Appointment · Overview · News. News. Print. 2025. Mayo Clinic researchers blaze a trail of rare ...

  2. Publications - Cumara B. O'Carroll, M.D., M.P.H. - Mayo Clinic

    Cumara B. O'Carroll, M.D., M.P.H.. Neurologist. Request an Appointment · Overview. Publications. Print. Chhabra N, O'Carroll CB, Wang H, Shahid A, Mbonde AA ...

  3. Study of Iomab-B Prior to HCT vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory AML - Mayo Clinic

    The primary objective of this study is to demonstrate the efficacy of Iomab-B, in conjunction with a Reduced Intensity Conditioning (RIC) regimen and protocol- ...

  4. Publications - Claire B. Haga, M.D. - Mayo Clinic

    Claire B. Haga, M.D.. Family Physician. Request an Appointment · Overview · Publications. Publications. Print. Dawson NL, Coombs SC, Haga CB, Prier CC, Walker ...

  5. Publications - Jonathan B. Hoyne, Ph.D. - Mayo Clinic

    ... B, Nicholson KA, Wszolek ZK, Hoyne JB, Gendron TF, Meschia JF, Petrucelli L ... B, Ritchie C, Lamb CJ, De Martino RR, Siegel J, Farres H, Hakaim AG ...

  6. Publications - Victor J. Pizzitola, M.D. - Mayo Clinic

    ... B. Relative Costs and Outcomes of a Contrast-Enhanced Mammography-Guided ... B, Palmieri J, Fraker J, Mina L, Batalini F, Pockaj B. Prospective Study ...

  7. Movement disorders - Doctors and departments - Mayo Clinic

    Andrew McKeon, M.B., ...

  8. Patient Stories - Carrie B. Hruska, Ph.D. - Mayo Clinic

    Search for a doctor. Carrie B. Hruska, Ph.D. Request an Appointment · Overview · Publications. Patient Stories. Print. PST-20225970. Home; Patient Stories ...

  9. Study of Iopofosine I 131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) and Pivotal Expansion in Waldenstrom Macroglobulinemia (CLOVER-WaM) - Mayo Clinic

    ... B-cell lymphoma (DLBCL) who have been previously treated with standard therapy for their underlying malignancy. Participation eligibility. Participant ...

  10. A Study of Acalabrutinib and Vistusertib in Subjects With Relapsed/Refractory B-cell Malignancies - Mayo Clinic

    A Study of Acalabrutinib and Vistusertib in Subjects With Relapsed/Refractory B-cell Malignancies. Print details. Share; Facebook · Twitter.